|
|
|
Stem Cell Related Patent Number US6569428
| Title: | Pharmaceutical products comprising endothelial cell precursors | | Inventors: | Isner, Jeffrey M.; Weston, MA, USA
Asahara, Takayuki; Arlington, MA, USA | | Summary: | This invention introduces novel methods of using endothelial progenitor cells. Described herein is a pharmaceutical product comprising a nucleic acid encoding an endothelial cell mitogen and endothelial cell (EC) progenitors, in a physiologically acceptable administrable form, wherein the EC progenitors are CD34+, Flk-1+, and tie-2+. Therapeutic applications are provided in the regulation of angiogenesis and in the treatment of tumors of ischemia, as well as in the treatment of injured blood vessels and in the detection of ischemic tissue or injured vessels in vivo. Further disclosed are pharmaceutical products comprising EC progenitors for use in the regulation of angiogenesis, whether in the enhancement or inhibition of blood vessel formation. Various embodiments of the invention include EC progenitors which can be used to enhance angiogenesis or to deliver an angiogenesis modulator to sites of angiogenesis, whether pathologic or utilitarian. Also provided are therapeutic uses of EC progenitors in inducing re-endothelialization of an injured blood vessel, and thus in reducing restenosis by indirectly inhibiting smooth muscle cell proliferation. | | Abstract: | | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6569428 | | Application Number: | US1999000228020 | | Date Filed: | 11/01/1999 | | Date Published: | 27/05/2003 | | Assignee: | St. Elizabeth's Medical Center of Boston, Inc., Boston, MA, USA |
|
|
